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N-methyl-D-aspartate (NMDA) receptors belong to the family
of ionotropic glutamate receptors (iGluRs) that mediate the
majority of fast excitatory synaptic transmission in the
mammalian brain. One of the hallmarks for the function
of NMDA receptors is that their ion channel activity is
allosterically regulated by binding of modulator compounds
to the extracellular amino-terminal domain (ATD) distinct
from the L-glutamate-binding domain. The molecular basis
for the ATD-mediated allosteric regulation has been enig-
matic because of a complete lack of structural information
on NMDA receptor ATDs. Here, we report the crystal struc-
tures of ATD from the NR2B NMDA receptor subunit in the
zinc-free and zinc-bound states. The structures reveal the
overall clamshell-like architecture distinct from the non-
NMDA receptor ATDs and molecular determinants for the
zinc-binding site, ion-binding sites, and the architecture of
the putative phenylethanolamine-binding site.
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Introduction
L-glutamate is the major excitatory neurotransmitter in the
mammalian brain and is critically involved in brain develop-
ment and function. Fast excitatory neurotransmission is
mediated by release of L-glutamate from nerve terminals
followed by activation of a class of ligand-gated ion channel
called ionotropic glutamate receptors (iGluRs) in the post-
synaptic membrane (Kandel et al, 1995). The iGluR family is
divided into three subfamilies based on pharmacological
sensitivity to the synthetic compounds, a-amino-3-hydroxy-
5-methyl-4-isoxazole propionic acid, kainate, and N-methyl-
D-aspartate (NMDA). Each subfamily comprises multiple
genes encoding subunit proteins that assemble as tetrameric
ion channels within the same group (Dingledine et al, 1999).
NMDA receptors are unique ligand-gated ion channels,
which require multiple events for activation, including the
binding of two agonists, L-glutamate and glycine, and the
relief of a Mg2þ block by membrane depolarization (Mayer
et al, 1984; Johnson and Ascher, 1987). In agreement with the
requirement of both glycine and L-glutamate for activation,
NMDA receptors are heterotetrameric ion channels composed
of two copies each of the obligatory glycine-binding NR1
subunit and the L-glutamate-binding NR2 and/or the glycine-
binding NR3 subunits (Cull-Candy et al, 2001). The four
distinct NR2 subunits (A–D) combine with the splice variants
of the NR1 subunit to convey multiple subtypes with distinct
ion channel properties and spatial and temporal expression
patterns (Monyer et al, 1994). The opening of NMDA receptor
ion channels results in influx of cations, including Ca2þ into
the postsynapse and activates signal transduction cascades
that control synaptic strength (MacDermott et al, 1986). This
coincidental integration of chemical and electrical information
into a Ca2þ signal is crucial for activity-dependent synaptic
plasticity underlying neuronal development and memory for-
mation (Kerchner and Nicoll, 2008; Sudhof and Malenka,
2008). In contrast, dysfunction of NMDA receptors is impli-
cated in numerous neurological diseases and disorders, in-
cluding seizure, stroke, Parkinson’s disease, Alzheimer’s
disease, and schizophrenia (Cull-Candy et al, 2001).
The architecture of NMDA receptors, like the other sub-
family members of iGluRs, is modular and is composed of
multiple domains with distinct functional roles (Figure 1A)
(Kuusinen et al, 1995). The large extracellular region of
iGluRs is partitioned into two domains, an amino-terminal
domain (ATD) and a ligand-binding domain (LBD) (S1S2).
The S1S2 LBD binds glutamate and glycine and elicits open-
ing of the ion channel pore formed by the transmembrane
domains (TM) in the heterotetrameric assembly. In the S1S2
domain, NMDA receptors and non-NMDA receptors have
rather high sequence similarity (B50% similar) and similar
overall architectures as revealed by recent crystallographic
studies (Armstrong and Gouaux, 2000; Furukawa and
Gouaux, 2003; Furukawa et al, 2005; Mayer, 2005; Yao
et al, 2008). In contrast, ATDs of NMDA receptors and non-
NMDA receptors have little or no sequence homology. Most
importantly, although there is no ATD-targeted ligand or
evidence for the ATD-mediated functional regulation in
non-NMDA receptors, there is a rich spectrum of small
ligands that bind the ATD of NMDA receptors and allosteri-
cally modulate ion channel activity (Paoletti and Neyton,
2007). These ligands are small molecules and ions including
polyamines, phenylethanolamines, or Zn2þ that bind to ATD
in a subunit-specific manner; that is, polyamines and protons
bind NR1 (Traynelis et al, 1995; Masuko et al, 1999), Zn2þ
binds both NR2A (Paoletti et al, 1997, 2000; Choi and Lipton,
1999; Fayyazuddin et al, 2000; Low et al, 2000) and NR2B
(Rachline et al, 2005), and phenylethanolamine compounds
bind NR2B (Perin-Dureau et al, 2002). In particular, zinc is
found at many excitatory synapses in the brain and thus is
likely to be a natural ligand of ATD (Paoletti et al, 2009).
From the clinical perspective, the ATD-mediated allosteric
modulation of NMDA receptors has evoked considerable
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interest because the effect of allosteric modulator compounds
is highly subtype specific (Gogas, 2006). In particular, the
phenylethanolamine compounds that target NR2B ATD have
high efficacy and specificity and show some promise as
neuroprotective agents without adverse side effects usually
observed with antagonists targeting the S1S2 LBDs (Gogas,
2006). However, despite a great deal of enthusiasm, knowl-
edge about the mechanism of the ATD-mediated allosteric
inhibition in NMDA receptors remains incomplete because of
lack of structural information on the NMDA receptor ATD.
Thus, to gain insight into the basic mechanisms underlying
recognition of allosteric modulator compounds at the NMDA
receptor ATD, we have obtained crystal structures of
the NR2B ATD in the zinc-free and zinc-bound states.
The structures reveal an overall clamshell-like architecture in
the closed conformation that is robustly different from the ones
observed in non-NMDA receptor ATDs (Clayton et al, 2009; Jin
et al, 2009; Kumar et al, 2009), and pinpoint the molecular
determinants for the zinc-binding site and the putative pheny-
lethanolamine-binding site at the clamshell cleft.
Results and discussion
Function of NR2B ATD
The NR2B NMDA receptor subunit has a modular molecular
organization like other members of the iGluR family
(Figure 1A), which allows the ATD to be isolated and
expressed recombinantly. Together with a signal peptide
from human placental alkaline phosphatase, the rat NR2B
ATD, defined as a peptide from Ser 31 to Met 394, can be
expressed as a secreted protein in the insect cell/baculovirus
system.
One of the hallmarks of NR2B-containing NMDA receptors
is that the ATD binds both Zn2þ or phenylethanolamine and
inhibits the ion channel activity in a non-competitive manner
(Perin-Dureau et al, 2002; Rachline et al, 2005). To examine
whether the recombinantly expressed NR2B ATD proteins
retain an ability to bind Zn2þ , we measured heat changes
resulting from an incremental addition of Zn2þ to the pur-
ified NR2B ATD protein by isothermal titration calorimetry
(Figure 1B). Fitting of the isotherm shows the presence of one
Zn2þ -binding site per protein molecule with Kd of 5.5 mM,
which is roughly comparable to the IC50 value for the Zn
2þ -
mediated allosteric inhibition of the NR1/NR2B NMDA
receptor ion channel activity (Rachline et al, 2005). Similar
NR2B ATD constructs expressed in Escherichia coli (Wong
et al, 2005; Han et al, 2008) are reported to bind ifenprodil
and related compounds as assessed by circular dichroism and
radio ligand-binding assay. Thus, the NR2B ATD proteins
studied here retain a functional characteristic of the intact
NR1/NR2B NMDA receptors.
Structure determination
To reveal the atomic structure of an NMDA receptor ATD, we
conducted a crystallographic study on NR2B ATD. The fol-
lowing manipulations were critical for obtaining a sufficient
quantity of the NR2B ATD protein suitable for crystallo-
graphic studies: (1) use of an amino-terminal octa-histidine
tag for purification with metal-chelating chromatography,
(2) mutation of one of the three putative N-linked glycosyla-
tion sites, Asn348 to Asp, and (3) use of a baculovirus strain
with deletion of viral genes, V-cath and chiA (Fitzgerald et al,
2006), together with the High Five cell-line. The combination
of the above manipulations improved the expression level by
five-fold and resulted in a yield of B0.5 mg of the homo-
geneously purified NR2B ATD protein per litre of insect cell
culture. Unlike non-NMDA receptors that form dimers in
solution with Kd of B150 nM (GluR2) and B10mM (GluR6),
the NR2B ATD proteins are monomers at 5 mg/ml (B120mM)
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Figure 1 Isolated NR2B ATD proteins bind zinc. (A) Domain organization of the NR2B subunit. ATD in cyan (R1 domain) and yellow (R2
domain) binds allosteric modulators including zinc and phenylethanolamine, S1S2 binds neurotransmitter L-glutamate, the transmembrane
domain (TM) and the P-loop (arrow) form the ion channel pore, and the C-terminal domain (CTD) binds postsynaptic molecules and mediates
intracellular signalling. NR2B ATD can be isolated and recombinantly expressed in insect cells. (B) ITC analysis of zinc binding to the NR2B
ATD protein. Upper panel, calorimetric titration of 0.8 mM ZnCl2 into 0.02 mM NR2B ATD. Lower panel, integrated heat as a function of Zn
2þ/
protein molar ratio with experimental data (filled squares) and the best fit (solid line). The Kd of zinc binding is calculated to be 5.5mM.
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as analysed by sedimentation velocity using analytical ultra-
centrifugation (Supplementary Figure S1).
To understand the molecular mechanism underlying zinc
recognition, the NR2B ATD proteins were crystallized in the
presence and absence of Zn2þ . In both cases, the NR2B
ATD proteins crystallized in space group P3121 with similar
unit cell dimensions and with one NR2B ATD protomer
per asymmetric unit. Despite the unusually high solvent
content of the crystals (77%), the x-ray diffraction limit of
the zinc-bound and zinc-free crystal extended to 3.2 and
2.8 A˚, respectively (Supplementary Table SI), which was
sufficient to unambiguously model most of the amino-acid
backbones and side chains starting from Pro 32 to Met 394
except for a disordered region between residues 208 and 214
(Figure 2; Supplementary Figure S2). The structure of the
zinc-free form was solved by multiple isomorphous replace-
ment with anomalous scattering (MIRAS) using single anom-
alous diffraction (SAD) datasets from crystals incorporated
with Ta6Br14, ErCl3, K2AuBr4, and L-selenomethionine
(SeMet) (Supplementary Table SI). The use of the above
four heavy atoms for phasing was necessary to obtain an
interpretable electron density map (Supplementary Figure S3).
Subsequently, the structure of NR2B ATD in the zinc-bound
state was obtained by molecular replacement using the zinc-
free structure as a search probe. After iterative rounds of
refinement, the final structures had acceptable conventional
R-factor and Rfree and stereochemical statistics (Supplementary
Table SII).
Overall architecture of NR2B ATD
The NR2B ATD has an overall clamshell-like architecture
composed of two domains, R1 and R2, which are tied
together by three well-structured loops (Figure 2). The crys-
tals grown in the presence and absence of zinc both contain
one NR2B ATD molecule per asymmetric unit. Consistent
with the result from sedimentation velocity, there is no
apparent evidence for a formation of physiological dimers.
This is in contrast to GluR2 and GluR6 ATDs, which form
dimers in solution as well as in crystals (Clayton et al, 2009;
Jin et al, 2009; Kumar et al, 2009). The packing pattern of the
NR2B ATD protomers in the P3121 crystal does not share any
common feature observed in GluR2 ATD or GluR6 ATD.
The NR2B ATD contains two types of posttranslational
modifications, N-linked glycosylation and a disulfide bond.
Clear electron density for N-acetyl-glucosamine is present at
the two N-linked glycosylations sites, Asn 74 and Asn 341,
both of which are located within the R1 domain. The first
ordered residue, Pro 32, is at the ‘top’ of R1, whereas the last
residue of the protein construct, Met 394, is at the ‘bottom’ of R2.
Thus, our NR2B ATD structure suggests that the beginning of
the S1S2 LBD in the NMDA receptor subunits is located at the
‘bottom’ portion of the R2 domain far away from the N-
terminus. The architecture of the R1 domain is further orga-
nized by the presence of a disulfide bond formed between two
conserved cysteine residues, Cys 86 from Helix 1 and Cys 321
from a ‘hypervariable loop’ (HVL; Figure 2). Similar disulfide
bonds are also observed in GluR2 and GluR6 ATDs. Thus, the
disulfide bond formation between Helix 1 and HVL is most
likely a conserved feature of all iGluR ATDs. The HVL (L1
‘flap’ and Loop 3 in GluR2 and GluR6, respectively) is formed
by the 15–20 amino-acid long linker between Helix 8 and 9 in
NR2B whose primary sequence is conserved within each
subfamily but is highly variable between the three subfamilies
(Supplementary Figure S2). In GluR2 and GluR6 ATDs, HVLs
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Figure 2 Overall architecture of NR2B ATD. (A) Ribbon representation of the NR2B ATD structure in complex with zinc. The clamshell-like
architecture of NR2B ATD is composed of two domains, R1 (cyan) and R2 (yellow), defined as residues 32–147 and 287–359 and residues
148–286 and 360–394, respectively. Hypervariable loop (HVL; in magenta) is oriented by a disulfide bond so that it covers the ‘top’ of the R1
domain. The disordered region (residues 208–214) between b7 and a5 is indicated with a dashed line. Stick representations are used to show
the disulfide bond (Cys 86–Cys 321), and sugar molecules attached to Asn 74 and Asn 341. Residues involved in zinc inhibition,
phenylethanolamine inhibition, and ion binding are represented by balls and sticks in blue, orange, and green, respectively. (B) View of
the NR2B ATD structure from the ‘entrance’ of the clamshell.
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protrude towards the homodimer interface, thus, they have
been suggested to have a function in a subtype-specific
assembly of iGluRs (Clayton et al, 2009; Jin et al, 2009;
Kumar et al, 2009). Because of the structural conservation
around the region, it is plausible that HVL also has a function
in subunit assembly in NMDA receptors.
The cleft of the NR2B ATD clamshell can be partitioned
into three different regions based on their chemical properties
and functional roles (Figure 2). First, the ‘hydrophilic pocket,’
which contains a cluster of polar residues including His 127
and Glu 284 involved in zinc binding (blue sticks). Second,
the ‘hydrophobic pocket’ at the inner core of the clamshell,
which contains a cluster of hydrophobic residues including
Ile 133, Ile 150, Phe 176, Tyr 231, and Leu 261 critical
for ifenprodil sensitivity (orange sticks). And third, the ‘ion-
binding site’ located in between the ‘hydrophilic’ and ‘hydro-
phobic’ pockets, which contains residues including Ser 131,
Phe 146, and Gln 153 and accommodates Na and Cl ions
(green sticks). In both zinc-bound and zinc-free structures,
Na and Cl ions are present at this ion-binding site.
Distinct architecture of NR2B ATD from non-NMDA
receptor ATDs
The overall fold of NR2B ATD has an approximate similarity to
non-NMDA receptor GluR2 ATD (Clayton et al, 2009; Jin et al,
2009) or GluR6 ATD (Kumar et al, 2009), but, with a signifi-
cantly distinct conformation. The root-mean-square deviation
of the entire ATD is high with values of 4.3 A˚ over 276 Ca
positions and 3.6 A˚ over 245 Ca positions between NR2B and
GluR2 and NR2B and GluR6, respectively. However, when the
R1 and R2 domains are individually superimposed, the root-
mean-square deviation values are significantly lower: 2.4 A˚
over 158 Ca positions (R1) and 2.2 A˚ over 145 Ca positions
(R2) between NR2B ATD and GluR2 ATD and 2.2 A˚ over 152
Ca positions (R1) and 1.9 A˚ over 142 Ca positions (R2)
between NR2B ATD and GluR6 ATD (Figure 3A). This major
difference is caused by the distinct R1–R2 domain orientation,
which in NR2B ATD, is ‘twisted’ by a striking rotation ofB45
and 541 compared with the R1–R2 orientation in GluR2 ATD or
GluR6 ATD (Figure 3C).
What could be a potential cause for this ‘twisted’ confor-
mation in NR2B ATD? The structural overlay shows a lack of
B30 residues between b-strand 10 and Helix 8 in NR2B ATD
compared with non-NMDA receptors (Figure 3A and C;
Supplementary Figure S2). These 30 residues in non-NMDA
receptors form a motif with an a helix that couples R1 and R2
(Jin et al, 2009; Kumar et al, 2009) and potentially stabilizes
the closed conformation of GluR2 and GluR6 ATD clamshell.
Thus, it is plausible that the lack of the helical motif in NR2B
ATD provides a structural freedom to orient the R1 and R2
domains in the ‘twisted’ conformation. The absence of this
structural motif is a general feature of all of the NMDA
receptor subunits, and therefore we suggest that the ‘twisted’
conformation observed in the current NR2B ATD structure
is a unique aspect of NMDA receptor ATD structures.
Furthermore, it is important to point out that this large
structural difference prevents the NR2B ATD protomers to
form a homo dimer in a similar protomer arrangement to that
observed in GluR2 or GluR6 ATD. For example, when two
copies of the NR2B ATD protomers are superimposed onto
the GluR6 ATD dimer at R1, most of the R2 residues from the
two protomers clash against each other (Supplementary
Figure S4). Thus, we suggest that the dimeric arrangement
of NMDA receptor ATDs is substantially different from that of
non-NMDA receptor ATDs.
The NR2B ATD also has distinct surface properties from
non-NMDA receptor ATDs. Of note is the presence of the large
hydrophobic patch at the ‘bottom’ of the R2 domain that is
only present in NR2B ATD (Figure 4). We propose that the
large hydrophobic patch may be a region that has a function
in inter-domain and/or inter-subunit interactions, which is
crucial for the ATD-mediated allosteric regulation. Overall,
the distinct structural features of NR2B ATD compared with
non-NMDA receptor ATDs described above may be critical in
eliciting the ATD-mediated regulation of the ion channel
activities, which is observed only in NMDA receptors but
not in non-NMDA receptors.
Structural comparison of NR2B ATD with mGluR LBD
The NR2B ATD structure also has a similar overall fold to the
LBDs of metabotropic glutamate receptors (mGluRs) and
atrial natriuretic peptide (ANP) receptors, and bacterial leu-
cine/isoleucine/valine-binding protein (LIVBP) as predicted
earlier by O’Hara et al (1993) although sequence identity of
the aligned region is only 11–16%. The most homologous
structure is the LBD of mGluR1 (PDB code: 1EWK)
(Kunishima et al, 2000), with a root-mean-square deviation
of 3.4 A˚ but over only 251 out of 365 possible Ca positions.
When the structures of the R1 and R2 domains are individu-
ally superimposed to the mGluR1 LBD structure, the root-
mean-square deviation is significantly lower with 2.4 A˚ for R1
and 2.0 A˚ for R2 over 150 and 143 Ca positions, respectively
(Figure 3B). This difference in the root-mean-square devia-
tion values, as in the case of the structural difference between
NR2B ATD and non-NMDA receptor ATDs, is due to the
‘twisted’ R1–R2 orientation of NR2B ATD (Figure 3D). The
R1–R2 orientation of GluR2 and GluR6 ATDs is similar to that
of mGluR LBDs, ANP receptor LBDs, and LIVBP. Thus, the
‘twisted’ conformation of NR2B ATD is unique among the
iGluRs and other families of receptors derived from LIVBP.
Zinc binds to NR2B ATD clamshell cleft
To reveal the molecular determinant for a zinc-binding site in
NR2B ATD, we solved the structure in complex with ZnCl2.
The crystallographic analysis of NR2B ATD shows that
the molecular determinants for the zinc-binding site are
distinct from those proposed for the hydrophobic pocket that
is implicated in phenylethanolamine sensitivity. Five zinc-
binding sites (Zn1–5) within the NR2B ATD protomer
are unambiguously identified by calculating the anomalous
difference Fourier map (Figure 5A). No anomalous peak is
observed when difference Fourier map at the zinc peak
wavelength (1.28 A˚) is calculated from data for zinc-free
crystals, indicating that zinc does not remain bound during
protein purification and that the zinc anomalous peak ob-
served in the zinc-bound NR2B ATD structure is derived from
zinc added to the crystallization solution. Among the five
zinc sites identified, Zn2, Zn3, and Zn5 are on the protein
surface, whereas Zn4 is at the crystallographic contact that is
likely to be non-physiological and Zn1 is at the inter-domain
cleft of the NR2B ATD clamshell containing residues
implicated in zinc sensitivity. Although binding of zinc ions
to the Zn2, 3, and 5 sites in the physiological condition
cannot be ruled out, there seems to be no functional role
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for these zinc ions because mutations of residues His 359, His
60, and His 311 to alanine, at the respective sites, do not cause
any major change in zinc sensitivity as assessed by dose–
response analyses by two electrode voltage-clamp (TEVC)
(Supplementary Table SIII). Consistent with this, earlier
electrophysiological studies have suggested the presence of
one zinc-binding site in NR2A ATD and NR2B ATD owing to
the observation that the zinc dose–response curves fit well
with single-binding site isotherms with a Hill coefficient
value of B1 (Paoletti et al, 1997; Rachline et al, 2005).
Thus, for the above reasons, we attribute Zn1 to be the
zinc-binding site responsible for the voltage-independent
zinc inhibition.
Zn1 is situated at the ‘hydrophilic pocket’ at the outer end
of the R1–R2 inter-domain cleft and is in close proximity to
the polar residues Glu 47, Asp 102, His 127, Asp 265, Asp
283, and Glu 284. Binding of Zn1 involves direct contact of
His 127 from R1 and Glu 284 from R2, which stabilizes the
closed clamshell conformation. Although involvement of His
127 has been shown earlier (Rachline et al, 2005), the critical
function of Glu 284 was not predicted from the mGluR1 LBD-
based homology model (Marinelli et al, 2007) because of a
large difference between the model and the current crystal
structure derived from the unexpected B501 twist between
R1 and R2 as described above. Other polar residues including
Glu 47 and Asp 265 face the Zn1 site, however, with no direct
contact with Zn1; the distances between the side chains of
Glu 47 and Asp 265 and Zn1 are 6.1 and 6.3 A˚, respectively.
Mutations of both Glu 47 and Asp 265 to alanine have been
shown earlier to reduce zinc sensitivity by four-fold (Rachline
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Figure 3 NR2B ATD has a different bi-lobe orientation from non-NMDA receptor ATD or mGluR1 LBD. (A) Superposition of the R1 (cyan,
upper panel) and R2 (yellow, lower panel) domains of NR2B ATD with the equivalent domains of GluR2 ATD (pink, PDB code: 3H5V, chain A)
and GluR6 ATD (light blue, PDB code: 3H6G, chain B). The regions of GluR2 ATD (Helix 8) and GluR6 ATD (Helix L), which are absent in NR2B
ATD, are highlighted in magenta and blue, respectively. Disulfide bonds are shown in sticks (arrow). The root-mean-square deviations are
2.37 A˚ (R1, 152 Cas) and 2.17 A˚ (R2, 142 Cas) and 2.18 A˚ (R1, 152 Cas) and 1.85 A˚ (R2, 142 Cas) for GluR2 and GluR6 ATDs, respectively.
(B) Superposition of NR2B ATD domains with the equivalent domains of mGluR1 LBD (grey, PDB code: 1EWK, chain A). The regions of
mGluR1 LBD, which are absent in NR2B ATD, are coloured in black. The root-mean-square deviations are 2.4 A˚ (R1, 150 Cas) and 2.0 A˚ (R2,
143 Cas). (C) Superposition of the R1 domains from GluR2 and GluR6 ATDs onto the R1 domain of NR2B ATD illustrates a large difference in
the pattern of the R1–R2 inter-domain orientation. The R2 domain of NR2B ATD is rotated by B45 and B541 relative to the R2 domains of
GluR2 and GluR6 ATDs, respectively. The reference rods (in black) for the angle measurement are drawn from the pivotal point of the rotation
(NR2B Pro 148, GluR2 Asp 131 and GluR6 Asp 152) to the last residue of b7 in all three structures. (D) The same manipulation as in
(C) illustrates the ‘twisted’ R1–R2 inter-domain orientation of NR2B ATD compared with mGluR1 LBD byB50o. The two reference rods for the
angle measurements in mGluR1 LBD are drawn from Pro 206 to the end of b8.
Crystal structure of NR2B ATD
E Karakas et al
The EMBO Journal VOL 28 | NO 24 | 2009 &2009 European Molecular Biology Organization3914
et al, 2005). Thus, although we cannot assign water mole-
cules at the current resolution (3.2 A˚), it is plausible that the
function of Glu 47 and Asp 265 may be to facilitate binding of
Zn1 indirectly by placing water molecules at the coordination
position through hydrogen bonds. Asp 101, Asp 102, and Thr
103 are on the loop that extends from b3 and towards the Zn1
site (Figure 5B). Among those residues, Asp 102 is facing the
Zn1 site but is distant from the zinc ion (46 A˚). Consistently,
the Asp102Ala mutation has been shown earlier to have no
effect on zinc sensitivity (Rachline et al, 2005). In contrast,
Asp 101 and Thr 103 are the residues that affect both
ifenprodil and zinc sensitivities when mutated to alanine
(Rachline et al, 2005). In the current crystal structure, both
Asp 101 and Thr 103 face the opposite direction to Zn1 and
form a hydrogen bond network with the main chain nitrogens
of Gly 129 and Ser 130 (Figure 5B). Thus, Asp 101 and Thr
103 are critical residues required to maintain the architecture
of the Zn1 pocket and the NR2B ATD clamshell structure as a
whole.
To test the physiological relevance of the current crystal
structure, we have mutated newly identified residues around
the Zn1 site, including Asp 283 and Glu 284, to alanine and
quantified zinc inhibition by measuring IC50 using TEVC.
Consistent with the current crystal structures, removal of the
zinc coordinating carboxylate groups by the Glu284Ala mu-
tation causes approximately a five-fold increase in the IC50
value (Figure 5C; Supplementary Table SIII). In contrast, an
alanine mutation of Asp 283, a residue that does not partici-
pate in the coordination of Zn1, only shows minor effect.
The His127Ala/Asp283Ala/Glu284Ala mutant has a similar
degree of change in IC50, indicating that disruption of either
His 127 or Glu 284 is sufficient to hamper the coordination of
Zn1. In all of the cases above, the mutants are only able to
shift the IC50 values to 5–6 mM. A similar effect has been
observed for the analysis of the high-affinity zinc inhibition
site in NR2A where mutations of the binding residues were
only able to shift the IC50 values to the low micromolar range
(Fayyazuddin et al, 2000). This is most likely attributed to the
presence of the low-affinity Zn2þ inhibitory site conserved
across the NR2 subtypes as suggested earlier by Neyton and
colleagues (Fayyazuddin et al, 2000).
Furthermore, mutation of all of the above residues has
little or no effect on ifenprodil sensitivity indicating that the
residues involved in Zn1 binding are distinct from those
involved in ifenprodil binding (Figure 5D). Earlier work has
shown that binding of zinc and ifenprodil compete with each
other (Rachline et al, 2005). Although a structural mechan-
ism cannot be established at present because of the lack of an
NR2B ATD structure in the ifenprodil-bound form, one pos-
sible explanation for the observation is that zinc blocks
ifenprodil from binding to the NR2B ATD clamshell by
keeping the clamshell conformation closed. Taken together,
the current crystal structure and electrophysiological data
clearly shows the direct involvement of His 127 and Glu
284 and indirect involvement of Glu 47 and Asp 265 in the
coordination of Zn1.
The NR2A-containing NMDA receptors are also allosteri-
cally inhibited by extracellular zinc (Paoletti et al, 1997) but
with much higher sensitivity than NR2B-containing NMDA
receptors; IC50 values of zinc inhibition are 16 and 760 nM for
NR2A and NR2B, respectively (Rachline et al, 2005). As the
ATDs of NR2A and NR2B are 56% identical, we predict that
the architecture around the Zn1 site is similar. Therefore, the
current structure of NR2B ATD along with an amino-acid
sequence alignment allows us to propose a potential mechan-
ism underlying the difference in zinc sensitivity between the
two subunits. The most notable difference between NR2A
and NR2B is on the loop that extends from b strand 1 and
90° 90°
NR2BA
B
GluR2 GluR6
R1
R2
R1
R2
Figure 4 Surface presentation of NR2B ATD and non-NMDA receptor ATDs. Surface presentation is coloured by hydrophobicity. (A) The R1
domains of NR2B, GluR2, and GluR6 ATDs are superimposed and viewed onto the dimer interface from the same angle. GluR6 ATD has a
notable hydrophobic patch composed of five hydrophobic residues in R2, whereas NR2B ATD has a smaller hydrophobic patch formed by Tyr
175, Tyr 179, and Leu 204. (B) The surface presentation viewed from the ‘bottom’ of the R2 domain. Unlike non-NMDA receptor ATDs, NR2B
ATD contains a large hydrophobic patch composed of Tyr 164, Trp 166, Ile 168, Phe 194, Val 195, Pro 226, Ile 227, Tyr 389, Val 390, and Trp 391.
Hydrophobicity was calculated using the hotpatch server (http://hotpatch.mbi.ucla.edu/). The surface was coloured from hydrophobic to
hydrophilic in a dark orange to white gradient.
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contains Glu 47 (Figure 5B). The equivalent region of NR2A
has additional two amino-acid residues and contains two
histidine residues, His 42 and His 44, which are critically
involved in zinc sensitivity (Fayyazuddin et al, 2000).
Consequently, His 42 and His 44 may be able to position
themselves in close proximity to Zn1 and form more ideal
coordination along with His 128 (His 127 in NR2B), and Asp
283 (Glu 284 in NR2B). Although the architecture of the zinc-
binding site between NR2A and NR2B may be distinct from
each other, we propose that a difference in the number of
direct coordination (four for NR2A and two for NR2B) may be
one of the factors underlying the large difference in zinc
sensitivity between the two subunits.
NR2B ATD in zinc-free form
The structure of NR2B ATD in a zinc-free form also captured
the closed cleft conformation in the current crystallographic
study (Figure 6A). Except for the Zn1-binding site where
there is a major structural rearrangement, the overall con-
formation of NR2B ATD in the zinc-free and zinc-bound
forms are similar to each other with a root-mean-square
deviation of 0.56 A˚ over 356 Ca positions (Supplementary
Figure S5). This observation is in contrast to LIVBP, which
undergoes a robust B501 clamshell closure on binding of
amino-acid ligands (Trakhanov et al, 2005) or to the mGluR1
LBD that also experiences significant clamshell closure on
binding of L-glutamate (Kunishima et al, 2000). Careful
inspection of the crystal structures in both the zinc-bound
and zinc-free forms reveals the presence of electron density
that represents one Na ion and three Cl ions deep in the
middle of the clamshell cleft between the zinc-binding site
and the hydrophobic pocket (Figure 6A and B). The presence
of Na and Cl ions are further confirmed by calculating
anomalous difference Fourier maps using data collected on
rubidium and bromide soaked crystals, respectively (Figure
6C and D). Rubidium, in general, binds better to sites, which
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Figure 5 Zinc-binding site. (A) Crystal structure of NR2B ATD in complex with zinc coloured as cyan (R1) and yellow (R2). The mesh in
magenta represents the zinc anomalous difference map contoured at 6.0 s. There are five zinc molecules identified per asymmetric unit (Zn1–5).
Zn4 and Zn40 are related by crystallographic symmetry. (B) Zoom up view of the Zn1 site. Zn1 is directly coordinated by the His 127 and Glu
284 side chains. Residues including Glu 47 and Asp 265 are too far from Zn1 (45 A˚) to make direct contacts but may be involved in placing
water molecules around Zn1 through hydrogen bonds. Side chain of Asp 102 beyond b carbon is disordered in the zinc-bound structure.
(C) Mutagenesis and the zinc dose–response curve showing an involvement of His 127 and Glu 284 in zinc sensitivity. Mutation of residues
directly involved in the Zn1 coordination (His 127 and Glu 284) has significant effect on zinc sensitivity, whereas that of non-contacting
residue, Asp 283, has minor effect. All of the recordings were done at the holding potential of 40 mV. The wild-type response is shown by a
dotted line. The error bars represent standard deviation for recordings from at least four different oocytes. (D) Fold difference in zinc and
ifenprodil sensitivities in each mutant. Mutation of the Zn1 site residues (His 127 and Glu 284) has a major effect on zinc sensitivity but little or
no effect on ifenprodil sensitivity.
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are selective for potassium. However, in the current structure,
it is able to replace the Na ion-binding site at the identical
position indicating that the cation-binding site is not highly
specific for Na ion. This observation is in parallel with Na ion
binding in the LBD of GluR6 where Na ions can be substi-
tuted with other monovalent cations, including Liþ , Kþ ,
Rbþ , and Csþ (Plested et al, 2008). Binding of the Na and
Cl ions involves residues from both R1 and R2 domains
(Figure 6B). Cl1 is located proximal to the hydrophobic
pocket and coordinated by main chain nitrogens of Ile 133,
Leu 261, and side chain of Gln 153, whereas Cl2 is proximal
to the zinc-binding site and is coordinated by side chains of
Ser 131 and Arg 292. Cl3 is located at the back side of the Zn1
site, which involve the main chain nitrogens of Trp 285, Asp
286, and Tyr 287 and the side chain of Arg 292 (Figure 6B).
The Na ion is located in between Cl1 and Cl2 and is
coordinated by main chain oxygen of Ser 131 and Phe 146
with the coordination distance of 2.2 and 2.3 A˚, respectively
(Figure 6B). These values are within an appropriate range of
the mean carbonyl-Naþ and carboxylate-Naþ distance ob-
served in the Protein data bank (2.42 A˚) (Harding, 2002).
Sodium ions are most commonly coordinated by six ligands
(Harding, 2002), thus, we anticipate that several water
molecules are also involved in the Naþ coordination even
though they are not clearly visible in the current structure
because of insufficient resolution. Can physiological concen-
tration of Naþ and Cl induce clamshell closure? To date,
there has not been any known mechanism for a functional
modulation of NMDA receptors by monovalent ions such as
Naþ and Cl like the ones observed in kainate receptors
(Plested and Mayer, 2007; Plested et al, 2008). Indeed, we
have not observed any significant change in the current–
voltage relationship by substitutions of Naþ by Liþ or Rbþ
or Csþ and Cl by NO3
 at 150 mM salt concentration (data
not shown). Thus, although binding of Naþ and Cl can take
place at the NR2B ATD clamshell cleft, it is likely not a driving
force for the clamshell closure.
It has recently been suggested that the NR2B ATD clamshell
can go through spontaneous oscillation between the open-cleft
and closed-cleft conformations favouring channel opening and
closing, respectively, and that binding of modulators including
zinc and phenylethanolamine shifts the conformational equili-
brium of ATD to the closed-cleft (Gielen et al, 2009). One of the
hallmarks of the NR2B NMDA receptors is its low ion channel
open probability and it has been shown that ATD is critically
involved in this process (Gielen et al, 2009). This implies that
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Figure 6 Structure of NR2B ATD in the zinc-free form. (A) The crystal structure of NR2B ATD in the absence of zinc at 2.8 A˚. The structure is
coloured as in Figure 2. The red mesh represents Fo-Fc omit map at 5.0 s for one Na ion and three chloride ions (Cl1–3) at the clamshell cleft.
(B) The zoom up view of the ion-binding site at the clamshell cleft. Na and Cl ions are coloured as purple and green, respectively. Residues
involved in ion binding, zinc binding, and phenylethanolamine binding are coloured in green, blue, and orange, respectively. (C) Anomalous
difference map at 3.3 s calculated from data collected on Rb soaked crystals showing that the density has an overlap with the Na-binding site.
(D) Anomalous difference map at 4.2 s calculated from data collected on Br soaked crystals showing that Br can substitute all of the Cl sites at
the cleft.
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NR2B ATD is favoured to be in the closed conformation even in
the absence of zinc and phenylethanolamine. Thus, it is plau-
sible that the current crystallographic study on the zinc-free form
may have simply captured the closed conformation—a more
favourable conformation than the open conformation in NR2B.
Residues at the R1–R2 interface have a significant function
in controlling the activity of NMDA receptors containing
NR2B. One notable residue is, Tyr282, a residue from R2
located deep in the middle of the clamshell cleft (Figure 6B).
Mutating Tyr 282 to cysteine and modifying it with methane
thiosulfonate (MTS) derivatives has been shown to dramati-
cally increase the open probability by locking the clamshell
open (Gielen et al, 2009). Furthermore, the alanine mutation
of Arg 292 from R2, which forms an inter-domain hydrogen
bond with the main chain oxygen of Tyr 282 and indirect
inter-domain interactions through Cl2 and Cl3, lowers po-
tency for zinc and ifenprodil inhibitions (Supplementary
Table SIII). On the basis of our current crystal structure, it
seems possible that the MTS modification of Tyr 282 or the
Arg292Ala mutation perturbs the architecture around the
clamshell cleft and destabilizes the closed conformation,
thereby shifting the conformational equilibrium of ATD to
the open-cleft form and favouring the opening of the ion
channels or the lowering potency of allosteric inhibition.
Taken together, the cleft residues at and around the ion-
binding site are important structural motif that controls the
opening and closing of the NR2B ATD clamshell and the ion
channel activity.
Hydrophobic pocket
The NR2B ATD clamshell contains a hydrophobic pocket at
the inner core of the cleft, which is formed by a cluster of
hydrophobic residues including Ile 133, Ile 150, Phe 176, Phe
182, Tyr 231, and Leu 261 (Figures 2, 6 and 7 in orange
sticks). Among these residues, mutations of the residues from
the R2 domain including Ile 150, Phe 176, Phe 182, Tyr 231,
and Leu 261 to alanine have been shown earlier to reduce
ifenprodil sensitivity significantly (Perin-Dureau et al, 2002;
Alarcon et al, 2008; Mony et al, 2009). Ile 133 is a residue
from the R1 domain, which extends towards the core of the
hydrophobic pocket. Indeed the side chain of Ile 133 is in van
der Waals contact with Ile 150, Phe 176, Tyr 231, and Leu 261.
To test whether this newly identified residue in the hydro-
phobic pocket, Ile 133, is involved in ifenprodil sensitivity,
we have mutated Ile 133 to alanine and serine and tested for
an ifenprodil dose–response using TEVC. Consistent with the
crystal structure, the Ile133Ala or Ile133Ser mutation has a
significant effect on ifenprodil sensitivity (Figure 7B). For
both Ile133Ala and Ile133Ser, data points can be fitted to two-
site model, but not one-site model Hill equation. It has been
shown earlier that the NR2B subunit contains two ifenprodil-
binding sites: a voltage-independent high-affinity site at ATD
and voltage-dependent low-affinity site at the ion channel
pore (Williams, 1993; Perin-Dureau et al, 2002). Thus, the
high- and low-affinity components in the Ile 133 mutants
likely represent the ATD-mediated inhibition and the ion
channel block present at 20 mV holding potential, respec-
tively (Figure 7B). The efficacy of the ATD-mediated ifenpro-
dil inhibition is 40% of the peak current in these mutants,
whereas the efficacy isB90% in wild type. Of interest to note
is the two modes of ifenprodil binding suggested recently by
homology modelling of NR2B ATD and docking of ifenprodil
(Mony et al, 2009). One possible explanation for the half
reduction of the ATD-mediated inhibition is that the mutation
may have hampered one of the two binding modes.
Furthermore, consistent with the crystal structure, mutations
of residues distant from the core of the hydrophobic pocket
including Pro148Gly, Pro148Ser, and Tyr356Ala, have little or
no effect on ifenprodil sensitivity (Figure 7B; Supplementary
Table SIII). Taken together, the hydrophobic pocket in the
NR2B ATD cleft is a key locus for ifenprodil sensitivity and
contains residues from both the R1 and R2 domains.
Unfortunately, despite extensive crystallization trials, we
have not been able to obtain the structure of the NR2B
ATD-ifenprodil complex.
Conclusion
This study provides the first molecular view of an NMDA
receptor ATD. The novel ‘twisted’ conformation of the NR2B
ATD maps previously unpredicted residues in the zinc-bind-
ing site and the putative phenylethanolamine-binding site.
Together with structure-based mutagenesis and electrophy-
siology, the study provides a molecular insight into the
recognition of zinc and elements that contribute to inhibition
by phenylethanolamines. Furthermore, this study has identi-
fied sodium- and chloride-binding sites at the clamshell cleft,
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Figure 7 Hydrophobic pocket is the critical structural locus for ifenprodil sensitivity. (A) Hydrophobic residues responsible for ifenprodil
sensitivity are clustered at the inner core of the NR2B ATD clamshell (in orange). Residues that have been mutated but had only minor effect are
coloured in grey. (B) Dose response of ifenprodil showing the critical involvement of Ile 133 in ifenprodil inhibition. Mutation of Ile 133 to
alanine or serine causes dramatic shift in ifenprodil sensitivity, whereas mutation of Tyr 356 to alanine has only minor effect. Data points for
both wild type and Tyr356Ala are fit to a single-site model, whereas those for the Ile 133 mutants are fit to a two-site model described in
‘Materials and methods.’ The IC50 values calculated by the fits are listed in Supplementary Table SIII. The wild-type response is shown as a
dotted line. All the currents were measured at the holding potential of 20 mV to minimize voltage-dependent pore block by ifenprodil.
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the function of which remains to be established. The struc-
tural information obtained in this study may be applicable to
understand the function of other NMDA receptor subunits.
Materials and methods
Expression, purification, and crystallization of NR2B ATD
The ATD of the rat NR2B (Ser 31 to Met 394) containing the
Asn348Asp mutation was N-terminally fused to human placental
alkaline phosphatase signal peptide followed by an octa-histidine
tag and a thrombin cleavage site. The NR2B ATD proteins were
expressed as secreted proteins using the High Five (Trichoplusia
ni)/baculovirus system (DH10multibac) (Fitzgerald et al, 2006).
The High Five cell culture (1.5106 cells/ml) grown in ESF921
medium (Expression System) was infected with the recombinant
virus harbouring NR2B ATD at multiplicity of infection of 5. After
48 h, the cell culture medium was collected, concentrated, and
dialysed against 200 mM NaCl and 20 mM Tris–HCl (pH 8.0) using
tangential flow filtration (Pall Corporation). NR2B ATD protein was
purified by metal chelate chromatography, cleaved by thrombin to
remove the N-terminal octa-histidine tag, and further purified by
size-exclusion chromatography.
To produce SeMet-incorporated NR2B ATD protein, the culture
medium was substituted with methionine-free ESF921 media 24 h
after viral infection. After 4 h, DL-SeMet (Sigma) at 50 mg/l was
added to the culture and the media was harvested 72 h after
infection. The proteins were purified as described above in the
presence of 2.5 mM methionine in all buffers to minimize oxidation
of the SeMet residues.
Both the native and the SeMet incorporated NR2B ATD proteins
were crystallized by hanging-drop vapour diffusion at 301C by
mixing the protein (8 mg/ml) with a reservoir solution containing
3.1–3.5 M NaCl, 2% PEG 400, 0.1 M MgCl2, and 0.1 M acetate (pH
5.5) in 2:1 ratio. Crystals were cryoprotected in 4.6 M NaCl, 2%
PEG400, and 0.1 M acetate (pH 5.5). Heavy atom derivatives for
phasing were obtained by soaking native crystals in the cryosolu-
tions supplemented with 0.2 mM Ta6Br16, 0.2 mM K2AuBr4, or 1 mM
ErCl3 for 1–5 h.
The NR2B ATD-zinc co-crystals were grown in a similar
condition but in the presence of 0.1 mM ZnCl2. The crystals were
further soaked against a solution containing 3 M NaCl, 1 mM ZnCl2,
and 0.1 M MES (pH 6.0) for 2 h and cryoprotected in 4.7 M NaCl,
1 mM ZnCl2, and 0.05 M MES (pH 6.0). To obtain bromide and
rubidium derivatives, the zinc-free NR2B ATD crystals were soaked
against 2 M Li2SO4, 1 M NaBr, and 0.1 M acetate (pH 5.5) for 2 h or
2 M RbCl and 1 M Mg-acetate (pH 5.0) for 1 min, respectively, and
crystals were flash frozen in the soaking solutions.
Data collection and structural analysis
All x-ray diffraction data were collected at the X25 and X29
beamlines at National Synchrotron Light Source and processed
using HKL2000 (Otwinowski and Minor, 1997). Diffraction data for
heavy atom derivatives was collected at their respective peak
wavelengths (Supplementary Table SI). Initially, three Ta6Br16
cluster sites were found by an SAD experiment at 6 A˚ resolution
using SOLVE (Terwilliger, 2004). The phase information from the
Ta6Br16 sites was used to calculate sites for Er, Au, and SeMet.
MIRAS was done using the program SHARP (de La Fortelle and
Bricogne, 1997). At this stage, a readily interpretable electron
density map was obtained (Supplementary Figure S3). A poly-
alanine model was built for 296 out of 365 residues using the
program RESOLVE. The rest of the model was built manually using
O (Jones and Kjeldgaard, 1997) and COOT (Emsley and Cowtan,
2004). Structural refinement was performed using the program
PHENIX (Adams et al, 2002) and REFMAC (Murshudov et al, 1997).
The structure of the zinc derivative was solved by molecular
replacement using coordinates of the R1 and R2 domains of NR2B
ATD as search probes and by conducting a multi-domain search in
the program PHASER (McCoy et al, 2007). Prime and Switch
phasing was carried out to remove model bias using the program
RESOLVE (Terwilliger, 2004). The zinc atoms were unambiguously
identified based on the anomalous difference Fourier map.
Isothermal titration calorimetry
NR2B ATD protein purified as above was extensively dialysed
against a buffer containing 20 mM Tris–HCl (pH 7.4) and 150 mM
NaCl and concentrated to B20 mM. Calorimetric titrations were
conducted on VP-ITC (MicroCal) and by successive injections of the
zinc titrant (0.8 mM ZnCl2) in 5ml increments for 40 times at 271C.
Data analysis was done using the software ORIGIN 7.0 (OriginLab).
Electrophysiology
Recombinant NR1/NR2B NMDA receptors were expressed by co-
injecting 0.1 ng of the rat NR1-1a and NR2B cRNAs at a 1:2 ratio
(w/w) into defolliculated Xenopus laevis oocytes. The two-electrode
voltage-clamp recordings were performed using agarose-tipped
microelectrodes (0.4–1.0 MO) filled with 3 M KCl at a holding
potential of 40 and 20 mV for zinc dose–response and ifenprodil
dose–response analysis, respectively. The bath solution contained
5 mM HEPES, 100 mM NaCl, and 0.3 mM BaCl2 at pH 7.3 (adjusted
with KOH). Peak currents were measured by adding 100mM each of
the agonists, glycine and L-glutamate, and NR2B ATD-mediated
inhibition was monitored in the presence of agonists and various
concentrations of ifenprodil or ZnCl2. For all of the zinc containing
buffers, pH was readjusted. The data were acquired and analysed by
the program Pulse (HEKA). Dose–response curves were plotted and
fit using the program IgorPro (Wavemetrics).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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